OXTRIPHYLLINE Drug Patent Profile
✉ Email this page to a colleague
When do Oxtriphylline patents expire, and when can generic versions of Oxtriphylline launch?
Oxtriphylline is a drug marketed by Morton Grove and Watson Labs and is included in four NDAs.
The generic ingredient in OXTRIPHYLLINE is oxtriphylline. There is one drug master file entry for this compound. Additional details are available on the oxtriphylline profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXTRIPHYLLINE?
- What are the global sales for OXTRIPHYLLINE?
- What is Average Wholesale Price for OXTRIPHYLLINE?
Summary for OXTRIPHYLLINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 1,713 |
| DailyMed Link: | OXTRIPHYLLINE at DailyMed |
US Patents and Regulatory Information for OXTRIPHYLLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morton Grove | OXTRIPHYLLINE | oxtriphylline | SOLUTION;ORAL | 088243-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Morton Grove | OXTRIPHYLLINE PEDIATRIC | oxtriphylline | SYRUP;ORAL | 088242-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | OXTRIPHYLLINE | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 087866-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | OXTRIPHYLLINE | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 087835-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
